小猪视频app

Form: 10QSB

Optional form for quarterly and transition reports of small business issuers

May 15, 1997

Documents

EXHIBIT 11

Published on May 15, 1997



Exhibit 11

CYTOCLONAL PHARMACEUTICS INC.


COMPUTATION OF NET (LOSS) PER COMMON SHARE
(unaudited)

Primary



Three Months Three Months
Ended Ended
March 31, March 31,
1996 1997
---------------------- -----------------------


Net (loss) ($657,000) ($738,000)

Add cumulative preferred dividend (345,000) (78,000)
---------- --------
NET (LOSS) USED FOR COMPUTATION ($1,002,000) ($816,000)

Weighted average number of common shares outstanding 7,569,918 7,934,488
---------- ---------
Net (loss) per common share ($0.13) ($0.10)























11